undefined undefined
NaN.000
NaN.00%
Barrington Research:维持Dave(DAVE.US)评级,由优于大市调整至优于大市评级, 目标价由45.00美元调整至65.00美元。
05-09 22:03
Analysts have been eager to weigh in on the Technology sector with new ratings ...
05-09 21:20
LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- Dave Inc. ("Dave" or the "Company...
05-09 04:05
During the last three months, 4 analysts shared their evaluations of Dave (NASD...
05-09 03:00
Dave (NASDAQ:DAVE) stock advanced 8.5% in Tuesday afternoon trading after the neobank raised its 2024 guidance following strong Q1 growth. The fintech that offers short-term loans and a debit card inc...
05-08 02:12
CMND: 60% | Clearmind Medicine shares are trading higher after the company signed an exclusive patent licensing agreement with Yissum Research Development Company. HIMS: 18% | Hims & Hers Health
05-07 20:36
2024 Financial Guidance ($ in millions) FY 2024 GAAP Operating Revenues, Net Year-Over-Year
05-07 19:38
Dave (NASDAQ:DAVE) reported quarterly earnings of $0.62 per share which beat the analyst consensus estimate of $(0.28) by 321.43 percent. The company reported quarterly sales of $73.600 million which beat the analyst
05-07 19:36
Dave (NASDAQ:DAVE) stock gapped up 13% in Monday morning trading after JMP Securities started coverage of the neobank and fintech company with a Market Outperform rating as analyst Devin Ryan sees too...
04-29 22:05
Barrington Research analyst Gary Prestopino upgrades Dave (NASDAQ:DAVE) from Market Perform to Outperform and announces $45 price target.
04-23 22:27